Back to all Entrepreneurs

Yiannis Kiachopoulos

Year Selected

London, United Kingdom

Follow Yiannis Kiachopoulos on LinkedIn

The AI Saving Time and Lives

Yiannis Kiachopoulos is yet another Greek founder that was ahead of the AI hype. Today, with 12 of the 20 biggest pharma giants relying on his plat- form, Causaly, Yiannis's vision is at the root of life-saving research.

Every great idea starts with a simple "what if?" For Yiannis and his co-founder Artur, it was about teaching a computer to read like The Flash. Being computer scientists and bookworms, the pair dreamt of extracting knowledge at superhuman speeds. They zeroed in on the biomedical domain, a field bursting with millions of publications and crucial to human health. And there they had it: an AI-driven platform that could sift through these vast data troves in seconds, squeezing weeks of research into a mere coffee break.

Fast forward to today, and Causaly is on fire! With a whopping $60 million in Series B fund- ing, the platform is set to redefine the future of drug discovery. The journey of drug development, often spanning over a decade, is being supercharged by Causaly's AI, which helps make sense of the intricate web of disease biology. The platform's hybrid approach, blending a top tier knowledge graph with cutting-edge generative AI, is empowering researchers to make novel discoveries with a tenfold boost in productivity.

From giants like Gilead and Novo Nordisk to regulatory bodies like the FDA, Causaly is becoming the go-to tool for scientific exploration.

In a world where AI often remains a buzzword, Causaly stands as a testament to its real-world impact.


ScaleUp Program
CausalyCEO & Co-Founder at Causaly

Year Founded


Year Selected



Growth (Series C+)

Team Size


Total Capital Raised


Enterprise Software & Services

Healthcare & Life Sciences

Data analytics

Cloud Computing, Infrastructure & Monitoring

Pharmaceuticals, Diagnostics & Life Sciences

Relevant Resources

See All

Endeavor Welcomes 17 New Companies to the ScaleUp Program with the Launch of its 3rd Batch

Jul 7, 2021